“In Vitro Biomimetic HPLC and in Vivo Characterisation of GM6, an Endogenous Regulator Peptide Drug Candidate for Amyotrophic Lateral Sclerosis”. ADMET and DMPK 6, no. 2 (June 16, 2018): 176–189. Accessed July 11, 2026. https://pub.iapchem.org/ojs/index.php/admet/article/view/547.